Beryl Drugs (BOM:524606) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beryl Drugs's Free Cash Flow for the three months ended in Mar. 2024 was ₹0.0 Mil. Beryl Drugs's Revenue for the three months ended in Mar. 2024 was ₹29.8 Mil. Therefore, Beryl Drugs's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Beryl Drugs's current FCF Yield % is 4.94%.

The historical rank and industry rank for Beryl Drugs's FCF Margin % or its related term are showing as below:

BOM:524606' s FCF Margin % Range Over the Past 10 Years
Min: -22.98 Med: -4.05 Max: 3.43
Current: -1.99

During the past 13 years, the highest FCF Margin % of Beryl Drugs was 3.43%. The lowest was -22.98%. And the median was -4.05%.

BOM:524606's FCF Margin % is ranked better than
57.73% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 0.475 vs BOM:524606: -1.99

Beryl Drugs FCF Margin % Historical Data

The historical data trend for Beryl Drugs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs FCF Margin % Chart

Beryl Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

-13.45

-5.16

-6.12

3.08

-1.99

Beryl Drugs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Beryl Drugs's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Beryl Drugs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beryl Drugs's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beryl Drugs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beryl Drugs's FCF Margin % falls into.

Beryl Drugs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beryl Drugs's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-5.314	/	267.296
	=	-1.99 %

Beryl Drugs's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	29.755
	=	0.00 %

Beryl Drugs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beryl Drugs (BOM:524606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001

Website

http://www.beryldrugs.com

Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs (BOM:524606) Headlines

No Headlines